Caitong International Asset Management Co., LTD Legend Biotech Corp Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Legend Biotech Corp stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 667 shares of LEGN stock, worth $23,098. This represents 0.02% of its overall portfolio holdings.
Number of Shares
667
Previous 970
31.24%
Holding current value
$23,098
Previous $31.6 Million
28.3%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
229Shares Held
74.4MCall Options Held
247KPut Options Held
406K-
Westfield Capital Management CO LP Boston, MA6.92MShares$240 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$233 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$207 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$198 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$130 Million5.57% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.8B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...